Pandanus Associates Inc. - Net Worth and Insider Trading
Pandanus Associates Inc. Net Worth
The estimated net worth of Pandanus Associates Inc. is at least $113 Million dollars as of 2024-12-28. Pandanus Associates Inc. is the 2201 Interest of corporation controlled by you of Cutia Therapeutics and owns about 17,440,385 shares of Cutia Therapeutics (HKSE:02487) stock worth over $113 Million. Details can be seen in Pandanus Associates Inc.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pandanus Associates Inc. has not made any transactions after 2024-05-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Pandanus Associates Inc.
Pandanus Associates Inc. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pandanus Associates Inc. owns 1 companies in total, including Cutia Therapeutics (HKSE:02487) .
Click here to see the complete history of Pandanus Associates Inc.’s form 4 insider trades.
Insider Ownership Summary of Pandanus Associates Inc.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:02487 | Cutia Therapeutics | 2024-05-31 | 2201 Interest of corporation controlled by you |
Pandanus Associates Inc. Latest Holdings Summary
Pandanus Associates Inc. currently owns a total of 1 stock. Pandanus Associates Inc. owns 17,440,385 shares of Cutia Therapeutics (HKSE:02487) as of May 28, 2024, with a value of $113 Million.
Latest Holdings of Pandanus Associates Inc.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:02487 | Cutia Therapeutics | 2024-05-28 | 17,440,385 | 6.47 | 112,839,291 |
Holding Weightings of Pandanus Associates Inc.
Pandanus Associates Inc. Form 4 Trading Tracker
According to the SEC Form 4 filings, Pandanus Associates Inc. has made a total of 5 transactions in Cutia Therapeutics (HKSE:02487) over the past 5 years, including 1 buys and 3 sells. The most-recent trade in Cutia Therapeutics is the sale of 1,529,200 shares on May 28, 2024, which brought Pandanus Associates Inc. around $14 Million.
Insider Trading History of Pandanus Associates Inc.
- 1
Pandanus Associates Inc. Trading Performance
GuruFocus tracks the stock performance after each of Pandanus Associates Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pandanus Associates Inc. is -1.64%. GuruFocus also compares Pandanus Associates Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Pandanus Associates Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Pandanus Associates Inc.'s insider trading performs compared to the benchmark.
Performance of Pandanus Associates Inc.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.81 |  | | | | |
| Relative Return to S&P 500(%) | 4.9 | | | | | |
Pandanus Associates Inc. Ownership Network
Pandanus Associates Inc. Owned Company Details
What does Cutia Therapeutics do?
Who are the key executives at Cutia Therapeutics?
Pandanus Associates Inc. is the 2201 Interest of corporation controlled by you of Cutia Therapeutics. Other key executives at Cutia Therapeutics include 2101 Beneficial owner Zhang Lele , 2201 Interest of corporation controlled by you Zhang Qiping , and 2201 Interest of corporation controlled by you su zhou tong yu tou zi guan li he huo qi ye you xian he huo .
Cutia Therapeutics (HKSE:02487) Insider Trades Summary
Over the past 18 months, Pandanus Associates Inc. made 4 insider transaction in Cutia Therapeutics (HKSE:02487) with a net sale of 3,165,600. Other recent insider transactions involving Cutia Therapeutics (HKSE:02487) include a net sale of 3,165,600 shares made by FIL Limited , a net sale of 3,165,600 shares made by Pandanus Partners L.P. , and a net sale of 80,600 shares made by YF Dermatology Limited .
In summary, during the past 3 months, insiders sold 0 shares of Cutia Therapeutics (HKSE:02487) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 10,397,200 shares of Cutia Therapeutics (HKSE:02487) were sold and 497,400 shares were bought by its insiders, resulting in a net sale of 9,899,800 shares.
Cutia Therapeutics (HKSE:02487)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cutia Therapeutics Insider Transactions
Pandanus Associates Inc. Mailing Address
Above is the net worth, insider trading, and ownership report for Pandanus Associates Inc.. Currently GuruFocus does not have mailing address information for Pandanus Associates Inc..
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
